Skip to main content

Hassanein Waleed H's Form 4 filing

TransMedics Group, Inc. (TMDX) · filed Jun 17, 2024

Accession no.
0000950170-24-074284
Filed
Jun 17, 2024
Trade date
Jun 14, 2024
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.22M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hassanein Waleed HCIK 0001430466Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 14, 2024Common StockMOption exerciseAcquired+8,625$13.28+$114,54070,268Direct
Jun 14, 2024Common StockSSaleDisposed−1,614$140.42−$226,637.8868,654Direct
Jun 14, 2024Common StockSSaleDisposed−3,836$141.62−$543,254.3264,818Direct
Jun 14, 2024Common StockSSaleDisposed−2,675$142.68−$381,66962,143Direct
Jun 14, 2024Common StockSSaleDisposed−400$143.65−$57,46061,743Direct
Jun 14, 2024Common StockSSaleDisposed−100$144.52−$14,45261,643Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 14, 2024Common StockMOption exerciseDisposed−8,625$0.00$0130,750Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)